Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
33.8M
-
Shares change
-
+809K
-
Total reported value, excl. options
-
$579M
-
Value change
-
+$15.8M
-
Put/Call ratio
-
0.33
-
Number of buys
-
54
-
Number of sells
-
-64
-
Price
-
$17.17
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q4 2018
144 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q4 2018.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.8M shares
.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (4.15M shares), MACQUARIE GROUP LTD (2.76M shares), BlackRock Inc. (2.62M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.21M shares), FRAZIER MANAGEMENT LLC (1.89M shares), FRANKLIN RESOURCES INC (1.83M shares), Rock Springs Capital Management LP (1.61M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.44M shares), Vanguard Group Inc (1.42M shares), and MILLENNIUM MANAGEMENT LLC (1.31M shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.